Brain-derived neurotrophic factor (BDNF) may not be the biomarker for Huntington’s disease that it was previously thought to be, a recent…
Articles by Forest Ray PhD
The first two patients have been enrolled in the high-dose group of a U.S. clinical trial testing the safety and efficacy…
Metabolites seen as potential biomarkers of Huntington’s disease — called kynurenine pathway metabolites — showed little evidence of Huntington’s-specific activity…
Stalled protein-building may underlie Huntington’s disease, according to data from a recent study. The findings showed that the mutated…
Wearable devices show considerable promise in helping diagnose people with Huntington’s disease, but the studies evaluating them need to…
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
The Hereditary Disease Foundation‘s (HDF) has announced the first winner of its Nancy S. Wexler Young Investigator Prize,…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the…
Microbes in the gut of people with Huntington’s or likely to develop this disease appear to differ from healthy peers,…